Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese

Clinical and genomic features of Chinese lung cancer patients with germline mutations

(2022) Wenying Peng et al.   Nature Communications

Rare germline deleterious variants increase susceptibility for lung cancer

(2022) Jian Sang et al.   HUMAN MOLECULAR GENETICS

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Rare deleterious germline variants and risk of lung cancer

(2021) Yanhong Liu et al.   npj Precision Oncology

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

(2021) Wei Cao et al.   CHINESE MEDICAL JOURNAL

Prevalence of BRCA1/BRCA2 pathogenic variation in Chinese Han population

(2020) Hui Dong et al.   JOURNAL OF MEDICAL GENETICS

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility

(2020) Mengyuan Liu et al.   Translational Lung Cancer Research

Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer

(2020) Stephen E. Lincoln et al.   JAMA Network Open

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome

(2020) N. Jewel Samadder et al.   JAMA Oncology

EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

(2019) Shun Lu et al.   Journal of Thoracic Oncology

New name for breast-cancer syndrome could help to save lives

(2019) Colin C. Pritchard   NATURE

Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations

(2019) Juncheng Dai et al.   Lancet Respiratory Medicine

Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing

(2019) Panwen Tian et al.   PATHOLOGY & ONCOLOGY RESEARCH

Determinants of utilisation rates of preventive health services: evidence from Chile

(2018) Elena S. Rotarou et al.   BMC PUBLIC HEALTH

Pathogenic Germline Variants in 10,389 Adult Cancers

(2018) Kuan-lin Huang et al.   CELL

Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer

(2018) Yanhong Liu et al.   Journal of Thoracic Oncology

Factors affecting participation in health checkups: Evidence from Japanese survey data

(2018) Riko Noguchi et al.   HEALTH POLICY

Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine

(2018) Laura Valle et al.   JOURNAL OF PATHOLOGY

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries

(2016) Lorelei A. Mucci et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Recurrent Mutation in PARK2 Is Associated with Familial Lung Cancer

(2015) Donghai Xiong et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2015) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability

(2015) Hsuan-Yu Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Germline EGFR T790M Mutation Found in Multiple Members of a Familial Cohort

(2014) Helena A. Yu et al.   Journal of Thoracic Oncology

Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study

(2012) F. Barone-Adesi et al.   BMJ-British Medical Journal

Unclassified variants in BRCA genes: guidelines for interpretation

(2011) P. Radice et al.   ANNALS OF ONCOLOGY

Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer

(2010) Maria Timofeeva et al.   INTERNATIONAL JOURNAL OF CANCER